Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q8NB91 (
FAB
)
3,573
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A micro method involving high-performance liquid chromatography-fast atom bombardment mass spectrometry (HPLC/
FAB
/MS) has been developed for the sensitive structural characterization of neutral glycosphingolipids and monosialogangliosides. The method involves a micro silica gel column (0.3 mm i.d. x 100 mm) and a micro HPLC apparatus working at a flow rate of 6 microliters/min. All injected materials can be structurally characterized by mass spectrometry without the splitting or wasting of materials, which was not possible with our previous method [M. Suzuki et al. (1990) J. Biochem. 108, 92-98]. A mixture containing 160 ng each of five neutral glycosphingolipids (GlcCer, LacCer, Gb3Cer,
Gb4Cer
, and IV3 alpha GalNAc-
Gb4Cer
) and a mixture containing 160 ng each of three monosialogangliosides [GM3(NeuAc), GM2(NeuAc), and GM1(NeuAc)] were injected into the micro HPLC with programmed elution with isopropanol-n-hexane-water with or without ammonium hydroxide. Each glycosphingolipid was separated by mass chromatography and the obtained mass spectra were suitable for structural characterization. Thus, the characterization of glycosphingolipids was achieved with small amounts of materials, 160 ng each, and in mixtures.
...
PMID:A micro method involving micro high-performance liquid chromatography-mass spectrometry for the structural characterization of neutral glycosphingolipids and monosialogangliosides. 186 4
We previously reported a method of high-performance liquid chromatography-fast atom bombardment mass spectrometry (HPLC/
FAB
/MS) for the structural characterization of molecular species of GlcCer and IV3 beta Gal-
Gb4Cer
[M. Suzuki et al. (1989) J. Biochem. 105, 829-833]. In this paper, we report a modification of this HPLC/
FAB
/MS method, which was used for the separation and characterization of neutral glycosphingolipids (GlcCer, LacCer, Gb3Cer,
Gb4Cer
, and IV3 alpha GalNAc-
Gb4Cer
) and monosialogangliosides [GM3(NeuAc or NeuGc), GM2 (NeuAc or NeuGc), and GM1 (NeuAc or NeuGc)]. Mixtures of the purified neutral glycolipids and monosialogangliosides were subjected to HPLC on a silica gel column, with programmed elution with isopropanol-n-hexane-water, with or without ammonium hydroxide. In order to obtain mass spectra and mass chromatograms of individual components, effluent from the HPLC column was mixed with a methanol solution of triethanolamine, which was used as the matrix for the
FAB
ionization, and one-thirtieth of the effluent mixture was introduced into a mass spectrometer through a frit interface. A mixture of the five neutral glycolipids, 5 micrograms of each, gave five peaks on a mass chromatogram obtained by monitoring of the corresponding major pseudo-molecular ions. A mixture of the six monosialogangliosides, 5 micrograms of each, gave six peaks on a mass chromatogram obtained by monitoring of the major pseudo-molecular ions, indicating that GM3, GM2, and GM1 were clearly separated, and that separation due to differences in sialic acid species was also achieved. In the mass spectra of the neutral glycolipids and monosialogangliosides, pseudo-molecular ions and fragment ions due to the elimination of sugar moieties were clearly detected.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:High-performance liquid chromatography-mass spectrometry of glycosphingolipids: II. Application to neutral glycolipids and monosialogangliosides. 222 16
A method of high-performance liquid chromatography-fast atom bombardment mass spectrometry (HPLC/
FAB
/MS) for the structural characterization of glycosphingolipids was developed, which involves a frit interface between the HPLC and the MS. The molecular species of glucosylceramide (GlcCer) purified from the spleen of a patient with Gaucher's disease and galactosylglobotetraosylceramide (IV3 beta Gal-
Gb4Cer
) from mouse kidney were analyzed using this system on a reversed-phase column, with methanol containing 1% glycerol as the elution solvent. The injection of 1 microgram of GlcCer gave the mass spectra of seven major molecular species, the pseudo-molecular ion for each of the seven molecular species being observed at m/z 698, 726, 754, 782, 808, 796, and 810, respectively. The injection of 200 pg of synthetic N-stearoyl glucosylsphingosine (d18:1) gave a clear peak with the single ion monitoring method detecting the pseudo-molecular ion at m/z 726. The injection of 5 micrograms of IV3 beta Gal-
Gb4Cer
gave the mass spectra of six major molecular species, the pseudo-molecular ions being observed at m/z 1,489, 1,471, 1,515, 1,497, 1,517, and 1,499. This report deals with a new HPLC/
FAB
/MS system, which was successfully applied to the structural characterization of the molecular species of neutral glycosphingolipids, and the system is a quite promising for development into a quantitative method for glycosphingolipids with high sensitivity and specificity.
...
PMID:High-performance liquid chromatography-mass spectrometry of glycosphingolipids: I. Structural characterization of molecular species of GlcCer and IV3 beta Gal-Gb4Cer. 275 78
Five neutral glycosphingolipids (GSLs) (
Gb4Cer
, Gb3Cer, LacCer, GlcCer and GalCer) were isolated from porcine erythrocyte membranes.
Gb4Cer
was the most abundant (over 70% of total neutral GSLs). In addition, a minor GSL fraction (less than 1% of the total), which migrated more slowly than Gb5Cer on TLC, composed of five GSLs. Two of them exhibited blood group A and O (H) activity, respectively, and were studied for their structures by spectrometries with NMR and
FAB
-mass, sequential hydrolysis by exoglycosidases, methylation and immunostaining. Chemical structure of the blood group A-antigen was proposed to be GalNAc alpha 1-3 (Fuc alpha 1-2) Gal beta 1-3 Gal-4Glc beta 1NAc beta 1-3 Gal beta 1-4 Glc beta 1-1Cer and GalNAc alpha 1-3 (Fuc alpha 1-2) Gal beta 1-4 GlcNAc beta 1-3 Gal beta 1-4Glc beta 1-1Cer. The blood group O (H)-antigen showed the structure lacking non-reducing terminal alpha-linked N-acetylgalactosamine from the A-antigen, or a biosynthetic precursor from of the A-antigen.
...
PMID:[A novel blood group A- and O (H) -antigens--glycosphingolipids from porcine erythrocytes]. 322 Apr 36